Business / Finance

RSS

Integrity Applications enters into distribution agreements for GlucoTrack device

Integrity Applications, Inc., developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into distribution agreements for the GlucoTrack device in Italy, Thailand and Uruguay.

10 Mar 2014

Omega Protein's fourth quarter 2013 revenues increase 4% to $66 million

Omega Protein Corporation, a nutritional product company and a leading integrated producer of omega-3 fish oil and specialty protein products, today reported financial results for the fourth quarter and full year ended December 31, 2013.

10 Mar 2014

WuXi Genome Center buys Illumina HiSeq X Ten sequencing system

Illumina, Inc. and WuXi PharmaTech (Cayman) Inc., a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with operations in China and the United States, today announced that the WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system.

From Illumina, Inc. 10 Mar 2014

UOC ventures into U.S. market to offer safe, cost-effective hip and knee devices

Today, United Orthopedic Corporation (UOC) - a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments - announced its entrance into the American market, offering clinically proven, safe and cost-effective hip and knee devices through its U.S. subsidiary, UOC USA.

7 Mar 2014

LVB Acquisition files registration statement for proposed initial public offering of common stock

Biomet, Inc. today announced that its parent company, LVB Acquisition, Inc., has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock.

7 Mar 2014

Nordion generates $70.8 million in revenue for first quarter of fiscal 2014

Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the first quarter of fiscal 2014.

7 Mar 2014

Mindray's ADS holders entitled to receive March 2014 dividend

Mindray Medical International Limited ("Mindray"), a leading developer, manufacturer, and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADS at the close of business on March 14, 2014 are entitled to the recently declared dividend ($0.50 per ordinary share).

From Mindray 7 Mar 2014

Columbia Laboratories repurchases Actavis' block of shares at advantageous price

Columbia Laboratories, Inc. announced today that the Company has repurchased 1.4 million shares of its common stock, par value $0.01 per share, from Coventry Acquisition, LLC, a subsidiary of Actavis Inc. (Actavis), at $6.08 per share, which represents a 10.75% discount to the closing price on Thursday, March 6, 2014.

7 Mar 2014

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Tetraphase Pharmaceuticals, Inc. today reported financial results for the quarter and full year ended December 31, 2013.

6 Mar 2014

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

Interactive Health announces acquisition of Health Solutions

Interactive Health, the leading provider of outcomes-based wellness programs, announced today an expansion of its capabilities with the acquisition of Health Solutions, an award-winning provider of onsite comprehensive wellness services to organizations in the United States and around the world.

6 Mar 2014

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at Debiopharm Research & Manufacturing S.A., its industrial development and production facility in Martigny (Valais, Switzerland), through acquisition of industrial high-value added activities or companies in the pharmaceutical, biotech or medtech field.

6 Mar 2014

Universal American reports net loss of $101.8 million for fourth quarter 2013

Universal American Corp. today announced financial results for the quarter and year ended December 31, 2013.

5 Mar 2014

Cross Country Healthcare's consolidated revenue decreases 2% to $109.2 million in Q4 2013

Cross Country Healthcare, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2013.

5 Mar 2014

Bio-Rad announces release of beta version of the USP Spectral Library

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the release of beta version of USP Spectral Library™ powered by Bio Rad's KnowItAll® software technology platform for spectral analysis, identification, search, data management, and reporting.

From Bio-Rad Laboratories 5 Mar 2014

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Agenus Inc., a biopharmaceutical company developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants, today announced its financial results and business highlights for the fourth quarter and year ended December 31, 2013.

5 Mar 2014

Metabolon agrees to provide biochemical profiling services to Human Longevity

Metabolon, Inc., the world's leading commercial-stage metabolomics company, announces the signing of an agreement with newly-launched Human Longevity Inc., whereby Metabolon will provide biochemical profiling services to assist HLI in its mission to tackle diseases of aging by building the world's largest and most complete human genotype, microbiome and phenotype database.

5 Mar 2014

POZEN reports total revenue of $4.7 million for fourth quarter 2013

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the fourth quarter and year ended December 31, 2013.

5 Mar 2014

Springer partners with Universit- degli Studi di Palermo to publish new English-language book series

Springer has entered into a partnership with Universit- degli Studi di Palermo to publish a new English-language book series. The UNIPA Springer Series is a unique cooperation that will showcase research from five core disciplines: medicine, biomedicine and life sciences; engineering and physics; mathematics, statistics and computer sciences; business, economics and law; and human, behavioral and social sciences.

5 Mar 2014

Eisai collaborates with Biogen Idec to develop and commercialize treatment options for AD

Eisai Co., Ltd. and Biogen Idec announced today that they have entered into a collaboration to develop and commercialize two of Eisai's clinical candidates for Alzheimer's disease (AD), E2609 and BAN2401.

5 Mar 2014

Business / Finance

Integrity Applications enters into distribution agreements for GlucoTrack device

Omega Protein's fourth quarter 2013 revenues increase 4% to $66 million

WuXi Genome Center buys Illumina HiSeq X Ten sequencing system

UOC ventures into U.S. market to offer safe, cost-effective hip and knee devices

LVB Acquisition files registration statement for proposed initial public offering of common stock

Nordion generates $70.8 million in revenue for first quarter of fiscal 2014

Mindray's ADS holders entitled to receive March 2014 dividend

Columbia Laboratories repurchases Actavis' block of shares at advantageous price

Tetraphase Pharmaceuticals reports net loss of $11.3 million for Q4 2013

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Interactive Health announces acquisition of Health Solutions

Debiopharm plans to expand, optimize activities at Martigny manufacturing facility

Universal American reports net loss of $101.8 million for fourth quarter 2013

Cross Country Healthcare's consolidated revenue decreases 2% to $109.2 million in Q4 2013

Bio-Rad announces release of beta version of the USP Spectral Library

Agenus reports net loss attributable to common stockholders of $5.8 million for Q4 2013

Metabolon agrees to provide biochemical profiling services to Human Longevity

POZEN reports total revenue of $4.7 million for fourth quarter 2013

Springer partners with Universit- degli Studi di Palermo to publish new English-language book series

Eisai collaborates with Biogen Idec to develop and commercialize treatment options for AD

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News